会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • CVT CONTROL USING STATE SPACE BASED GAIN SCHEDULING
    • 使用基于状态空间的增益调度的CVT控制
    • WO2012134869A3
    • 2012-12-27
    • PCT/US2012029725
    • 2012-03-20
    • CATERPILLAR INCLI WEIHOFF BRIAN
    • LI WEIHOFF BRIAN
    • F16H59/36F16H59/44F16H61/66
    • F16H61/465B60W10/06B60W10/103B60W30/1884B60W2710/1005B60W2710/1061F16H61/431F16H2059/366F16H2059/6853
    • An engine powered wheeled machine having improved engine over speed and under speed protection includes a parallel path transmission having a gear train with first and second transmission inputs and a transmission output, and including a hydraulic variator having a variator output driving the first transmission input, the hydraulic variator having a variator pump and a variator motor, the displacement of the variator pump being controlled by a variator actuator. The machine further includes an engine having an engine output driving the second transmission input and driving the variator pump and a controller for receiving one or more values indicative of one or more ranges of permissible engine speed, a value indicative of an actual engine speed, and a value indicative of the position of the variator actuator, with the controller being configured to control the position of the variator actuator based on state space gain mapping to maintain the engine speed within the one or more ranges of permissible engine speed.
    • 具有改进的发动机超速和低速保护的发动机动力轮式发动机包括具有带有第一和第二变速器输入和变速器输出的齿轮系的并行路径变速器,并且包括具有驱动第一变速器输入的变速器输出的液压变速器, 具有变速泵和变速马达的液压变速器,变速泵的位移由变速器致动器控制。 该机器还包括具有驱动第二变速器输入并驱动变速泵的发动机输出的发动机和用于接收表示允许的发动机转速的一个或多个范围,表示实际发动机转速的值的一个或多个值的控制器,以及 指示变速器致动器的位置的值,其中控制器被配置为基于状态空间增益映射来控制变换器致动器的位置,以将发动机速度维持在允许的发动机转速的一个或多个范围内。
    • 12. 发明申请
    • ISOLATION AND EXPANSION OF ANIMAL CELLS IN CELL CULTURES
    • 细胞培养中动物细胞的分离和扩增
    • WO2008002329A3
    • 2008-07-17
    • PCT/US2006049500
    • 2006-12-28
    • TISSUETECH INCTSENG SCHEFFERHE HUALI WEICHEN YING-TINGHAYASHIDA YASUTAKA
    • TSENG SCHEFFERHE HUALI WEICHEN YING-TINGHAYASHIDA YASUTAKA
    • C12N5/02C12N5/071C12N5/074
    • C12N5/0621C12N5/0605C12N2500/90
    • Described are methods for isolating/purifying and expanding animal stem cells and stem-celHike cells. Isolation methods include conditions comprising preferentially digesting non-stem cells and non-stem-cell-like cells in a population and preferentially adhering stem cells and stem-cell-like cells in a population. Expansion methods include culturing such cells under conditions comprising modulation of TGF-ß signaling, inhibition of cell signaling mediated by p38 MAP kinase using small molecular weight inhibitors, expansion of the cells on human amniotic epithelial cells as feeder layers, control of cell seeding density, control of levels Of Ca2+ in the culture media, rapid adhesion on a substrate or by a combination of such conditions. More particularly, what is disclosed relates to methods and systems for expanding animal cells in ex vivo cell cultures, while preventing cellular differentiation, and selectively enriching stem cells. The embodiments also disclose a culture system for ex vivo expansion of limbal epithelial cells or mesenchymal cells, as well as surgical grafts made there from.
    • 描述了分离/纯化和扩增动物干细​​胞和干细胞样细胞的方法。 分离方法包括包含优先消化群体中的非干细胞和非干细胞样细胞并且优先将干细胞和干细胞样细胞粘附于群体中的条件。 扩增方法包括在包含TGF-β信号传导的调节,使用小分子量抑制剂抑制由p38MAP激酶介导的细胞信号传导的条件下培养此类细胞,作为饲养层的细胞在人羊膜上皮细胞上的扩增,细胞接种密度的控制, 控制培养基中Ca 2+的水平,在基质上的快速粘附或通过这些条件的组合。 更具体地,公开的内容涉及用于在体外细胞培养物中扩增动物细胞,同时防止细胞分化和选择性富集干细胞的方法和系统。 这些实施方案还公开了用于离体扩展角膜缘上皮细胞或间充质细胞的培养系统,以及由其制造的手术移植物。
    • 16. 发明申请
    • AUTOMATIC NETWORKING APPARATUS AND SYSTEM FOR VEHICLES
    • 车辆自动联网装置和系统
    • WO2013088210A1
    • 2013-06-20
    • PCT/IB2012000684
    • 2012-04-04
    • SHANGAI BAOLONG AUTOMOTIVE CORPHU JUNFENGSHI WEIHUALI WEI
    • HU JUNFENGSHI WEIHUALI WEI
    • B60R16/023B60D1/62B60K35/00B60P9/00H04L12/28
    • B60D1/62H04L67/12
    • A vehicle automatic networking apparatus with a first component and a second replaceable component includes a first identity recognition module on the first component and a second identity recognition module on the second component. The second module in a networking mode transmits a low frequency wake up signal through a low frequency signal transmission circuit to wake up the first module. A first identity recognition module low frequency sensor circuit senses the low frequency wake up signal, and responds by transmitting an identity code of the first component through a low frequency signal transmission circuit. A second module low frequency signal receiving circuit receives and stores the first component identity code. In a following data transmission, the second module sends data with the identity code, and a first component receiving apparatus identifies it. The first and second modules are both located rearward of a second component connection hitch.
    • 具有第一组件和第二可替换组件的车辆自动联网设备包括在第一组件上的第一身份识别模块和在第二组件上的第二身份识别模块。 处于联网模式的第二模块通过低频信号传输电路传输低频唤醒信号以唤醒第一模块。 第一身份识别模块低频传感器电路感测低频唤醒信号,并且通过经由低频信号传输电路传输第一组件的识别码来响应。 第二模块低频信号接收电路接收并存储第一组件识别码。 在接下来的数据传输中,第二模块发送带有身份代码的数据,第一组件接收设备识别它。 第一和第二模块都位于第二组件连接挂钩的后方。
    • 20. 发明申请
    • VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
    • 疫苗组合物及其使用方法
    • WO2010115046A2
    • 2010-10-07
    • PCT/US2010029694
    • 2010-04-01
    • UNIV MIAMIDAFTARIAN PIROUZ MOHAMMADSERAFINI PAOLOLEMMON VANCE PAULLI WEIKAIFER ANGELBLOMBERG BONNIE BETHPEREZ VICTOR L
    • DAFTARIAN PIROUZ MOHAMMADSERAFINI PAOLOLEMMON VANCE PAULLI WEIKAIFER ANGELBLOMBERG BONNIE BETHPEREZ VICTOR L
    • A61K39/145
    • A61K39/0011A61K39/12A61K39/145A61K2039/53A61K2039/55516A61K2039/55555A61K2039/645C08G83/006C12N2760/16022C12N2760/16034G01N2333/70539
    • Nanoparticle -based vaccines, compositions, kits and methods are used for the effective delivery of one or more antigens in vivo for vaccination and antibody (e.g., monoclonal antibody) production, and for the effective delivery of peptides, proteins, siRNA, RNA or DNA to PAPCs or MHC class II positive cells (e.g. tumor cells). Antigens may be, for example, DNA that results in expression of the gene of interest and induction of a robust and specific immune response to the expressed protein in a subject (e.g., mammal). Antigens may also be immunogenic peptides or polypeptides that are processed and presented. In one embodiment, a nanoparticle -based method to deliver antigens in vivo as described herein includes injection of a vaccine composed of a DNA encoding at least one antigen, or at least one antigenic peptide or polypeptide conjugated to a charged dendrimer (e.g., PADRE-derivatized dendrimer) that is also conjugated to a T helper epitope (e.g., PADRE). Negatively-charged plasmids bind naturally to a positively-charged PADRE-dendrimer, while peptide or polypeptide antigens can be chemically linked to the PADRE-dendrimer if they are not negatively-charged. Alternatively, negatively-charged dendrimers may be used. The compositions, kits, vaccines and methods described herein have both prophylactic and treatment applications, i.e., can be used as a prophylactic to prevent onset of a disease or condition in a subject, as well as to treat a subject having a disease or condition. A vaccine as described herein can be used to mount an immune response against any infectious pathogen or cancer.
    • 基于纳米颗粒的疫苗,组合物,试剂盒和方法用于体内有效递送一种或多种抗原用于疫苗接种和抗体(例如单克隆抗体)生产以及有效递送肽,蛋白质,siRNA,RNA或DNA 到PAPC或MHC II类阳性细胞(例如肿瘤细胞)。 例如,抗原可以是导致感兴趣基因表达并诱导受试者(例如哺乳动物)中所表达的蛋白质的强烈和特异性免疫应答的DNA。 抗原也可以是经过处理和呈递的免疫原性肽或多肽。 在一个实施方案中,如本文所述的体内递送抗原的基于纳米粒子的方法包括注射由编码至少一种抗原的DNA组成的疫苗或缀合至带电荷的树状聚体的至少一种抗原性肽或多肽(例如PADRE- 衍生的树枝状聚合物),其也与T辅助表位(例如,PADRE)缀合。 带负电荷的质粒自然结合带正电荷的PADRE-树状聚体,而肽或多肽抗原可以化学连接至PADRE-树状聚合物(如果它们不带负电荷的话)。 或者,可以使用带负电的树枝状聚合物。 本文所述的组合物,试剂盒,疫苗和方法具有预防和治疗应用,即可用作预防以预防对象中疾病或病症的发作,以及治疗患有疾病或病症的对象。 如本文所述的疫苗可用于产生针对任何感染性病原体或癌症的免疫应答。